Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice
J. Clin. Invest. Chang-yun Hu, et al. 117:3857 doi:10.1172/JCI32405 [Go to this article.]

Figure 4
Diabetes incidence following 2H7 or control IgG treatment at different ages. (A) Four-week-old and (B) 9-week-old hCD20 female mice were treated 4 times within 10 days with 2H7 (closed squares; n = 12) or control IgG (open squares; n = 12) antibodies and monitored for diabetes.